Editas Medicine, Inc. (EDIT)

NASDAQ: EDIT · Real-Time Price · USD

2.620

-0.060 (-2.24%)

At close: Jul 28, 2026, 4:00 PM EDT

2.590

-0.030 (-1.15%)

After-hours: Jul 28, 2026, 7:56 PM EDT

Editas Medicine Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	402	201	105	828	611	1,817
Market Cap Growth	52.48%	90.94%	-87.31%	35.64%	-66.39%	-58.58%
Enterprise Value	295.72	130.69	-72.37	541.73	310.35	1,343
Last Close Price	2.62	2.05	1.27	10.13	8.87	26.55

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	10.39	4.95	3.25	10.60	30.98	71.13
PB Ratio	58.19	7.35	0.78	2.37	1.69	3.28
P/TBV Ratio	54.93	6.67	0.78	2.20	1.69	3.24

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	7.64	3.23	-2.24	6.93	15.74	52.60
EV/EBITDA Ratio	-	-	0.29	-	-	-
EV/EBIT Ratio	-	-	0.29	-	-	-
EV/FCF Ratio	-	-	0.33	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	13.11	2.41	0.54	0.07	0.09	0.03
Net Debt / Equity Ratio	-11.72	-2.56	-1.32	-0.82	-0.83	-0.85
Net Debt / EBITDA Ratio	0.49	0.45	0.72	1.76	1.37	2.52
Net Debt / FCF Ratio	0.37	0.42	0.81	2.09	1.66	2.76
Asset Turnover	0.23	0.15	0.08	0.15	0.03	0.04
Quick Ratio	3.17	3.50	3.71	5.27	5.81	10.67
Current Ratio	3.22	3.54	3.75	5.39	5.94	10.82
Return on Equity (ROE)	-687.49%	-198.14%	-98.10%	-43.17%	-48.22%	-40.65%
Return on Assets (ROA)	-64.82%	-60.60%	-59.75%	-33.39%	-37.92%	-30.90%
Return on Invested Capital (ROIC)	-314.86%	-303.06%	-207.21%	-99.77%	-129.44%	-113.35%
Return on Capital Employed (ROCE)	-87.13%	-79.09%	-71.73%	-38.01%	-41.66%	-33.74%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Buyback Yield / Dilution	-11.90%	-7.78%	-8.39%	-10.63%	-1.55%	-15.37%
Total Shareholder Return	-11.90%	-7.78%	-8.39%	-10.63%	-1.55%	-15.37%

SEC Filings: 10-K · 10-Q